JPWO2020033715A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020033715A5 JPWO2020033715A5 JP2021506687A JP2021506687A JPWO2020033715A5 JP WO2020033715 A5 JPWO2020033715 A5 JP WO2020033715A5 JP 2021506687 A JP2021506687 A JP 2021506687A JP 2021506687 A JP2021506687 A JP 2021506687A JP WO2020033715 A5 JPWO2020033715 A5 JP WO2020033715A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- optionally substituted
- substituted substituent
- cancer
- gitr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024120839A JP2024156758A (ja) | 2018-08-08 | 2024-07-26 | 癌及び自己免疫疾患を治療するための組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862716101P | 2018-08-08 | 2018-08-08 | |
| US62/716,101 | 2018-08-08 | ||
| PCT/US2019/045742 WO2020033715A1 (en) | 2018-08-08 | 2019-08-08 | Compositions and methods for treating cancer and autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024120839A Division JP2024156758A (ja) | 2018-08-08 | 2024-07-26 | 癌及び自己免疫疾患を治療するための組成物及び方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021534110A JP2021534110A (ja) | 2021-12-09 |
| JP2021534110A5 JP2021534110A5 (https=) | 2022-08-02 |
| JPWO2020033715A5 true JPWO2020033715A5 (https=) | 2022-08-02 |
| JP7530346B2 JP7530346B2 (ja) | 2024-08-07 |
Family
ID=69415674
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506687A Active JP7530346B2 (ja) | 2018-08-08 | 2019-08-08 | 癌及び自己免疫疾患を治療するための組成物及び方法 |
| JP2024120839A Pending JP2024156758A (ja) | 2018-08-08 | 2024-07-26 | 癌及び自己免疫疾患を治療するための組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024120839A Pending JP2024156758A (ja) | 2018-08-08 | 2024-07-26 | 癌及び自己免疫疾患を治療するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210299176A1 (https=) |
| EP (1) | EP3833323A4 (https=) |
| JP (2) | JP7530346B2 (https=) |
| KR (2) | KR102753455B1 (https=) |
| CN (2) | CN112739314A (https=) |
| CA (1) | CA3108796A1 (https=) |
| WO (1) | WO2020033715A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220370586A1 (en) * | 2019-08-08 | 2022-11-24 | Cedars-Sinai Medical Center | Method of generating activated t cells for cancer therapy |
| CN113429488B (zh) * | 2021-07-14 | 2022-08-30 | 海正生物制药有限公司 | GITR/TGF-β双靶向融合蛋白及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3270960A (en) | 1964-09-11 | 1966-09-06 | Sperry Rand Corp | Fluid sensor |
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| CA1292686C (en) | 1986-10-27 | 1991-12-03 | Ze'ev Shaked | Pharmaceutical compositions of recombinant interleukin-2 and formulation process |
| CA1294215C (en) | 1986-10-27 | 1992-01-14 | Ze'ev Shaked | Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| ZA200509143B (en) * | 2003-05-23 | 2007-03-28 | Wyeth Corp | GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| TW200800230A (en) * | 2006-03-31 | 2008-01-01 | Dynamis Therapeutics Inc | Composition and method related to fructosamine-3-kinase inhibitors |
| JP2008278814A (ja) | 2007-05-11 | 2008-11-20 | Igaku Seibutsugaku Kenkyusho:Kk | アゴニスティック抗ヒトｇｉｔｒ抗体による免疫制御の解除とその応用 |
| SG10201912986PA (en) * | 2014-05-28 | 2020-02-27 | Agenus Inc | Anti-gitr antibodies and methods of use thereof |
| JP2018503373A (ja) * | 2014-12-30 | 2018-02-08 | ジェネンテック， インコーポレイテッド | がんの予後診断及び治療のための方法及び組成物 |
| PL3242947T3 (pl) | 2015-01-09 | 2021-01-11 | Oncosec Medical Incorporated | Terapia genowa i elektroporacja do leczenia zmian złośliwych |
-
2019
- 2019-08-08 KR KR1020217006602A patent/KR102753455B1/ko active Active
- 2019-08-08 JP JP2021506687A patent/JP7530346B2/ja active Active
- 2019-08-08 CN CN201980062092.7A patent/CN112739314A/zh active Pending
- 2019-08-08 KR KR1020257000546A patent/KR20250025409A/ko active Pending
- 2019-08-08 CA CA3108796A patent/CA3108796A1/en active Pending
- 2019-08-08 EP EP19848154.1A patent/EP3833323A4/en active Pending
- 2019-08-08 US US17/266,488 patent/US20210299176A1/en active Pending
- 2019-08-08 CN CN202410436075.8A patent/CN118662499A/zh active Pending
- 2019-08-08 WO PCT/US2019/045742 patent/WO2020033715A1/en not_active Ceased
-
2024
- 2024-07-26 JP JP2024120839A patent/JP2024156758A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6279605B2 (ja) | 自己免疫疾患および炎症性疾患の処置に使用するためのレチノイド関連オーファン受容体ガンマ（ＲＯＲγ）のモジュレーター | |
| JP6155395B2 (ja) | 新規ｄｇａｔ２阻害剤 | |
| ES2297150T7 (es) | Antagonistas triciclicos de receptores de trombina. | |
| ES2538655T3 (es) | 3-Amino-piridinas como agonistas de GPBAR1 | |
| US10463644B2 (en) | Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation | |
| JP5992615B2 (ja) | 抗癌剤であるシクロプロパンカルボキサミドで置換された芳香族化合物 | |
| TW200825065A (en) | Pyrazine-2-carboxamide derivatives | |
| US11974997B2 (en) | RORgamma modulators and uses thereof | |
| JP5542946B2 (ja) | Ｃｃｒ１受容体アンタゴニストとしてのインダゾール及びピラゾロピリジン化合物 | |
| EP3126349A1 (en) | 5,6-disubstituted pyridine-2-carboxamides as cannabinoid receptor agonists | |
| JP2021534110A5 (https=) | ||
| JP2017509676A (ja) | Ｃｂ２アゴニストとして有用なピリジン−２−アミド | |
| CN109803964A (zh) | 磺酰基吡啶基trp抑制剂 | |
| JPWO2020033715A5 (https=) | ||
| CN104151391B (zh) | 一种具有抗肿瘤作用的齐墩果酸衍生物及其制备方法和用途 | |
| JP6100755B2 (ja) | （２−ヘテロアリールアミノ）コハク酸誘導体 | |
| JP2025501370A (ja) | ステロイド系化合物および製造方法と使用 | |
| Park et al. | Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists | |
| JP5762548B2 (ja) | Ｎ−ピリジン−３−イル又はｎ−ピラジン−２−イルカルボキサミド類 | |
| JP2016504397A (ja) | Ｃｒａｃチャネル阻害薬としての、ピラゾリルをベースとするカルボキサミド類ｉｉ | |
| JP7254703B2 (ja) | Ｒｏｒガンマモジュレーター及びその使用 | |
| US20130109720A1 (en) | Indole inhibitors of crac | |
| JP2016102128A (ja) | 新規３−アザビシクロ［３．１．０］ヘキサン誘導体及びその医薬用途 | |
| JP5815874B2 (ja) | Ｈｄｌコレステロール上昇剤としての３−ピリジンカルボン酸ヒドラジド | |
| CN104829591A (zh) | 氘代匹莫齐特的制备方法 |